A prospective cohort study of the incidence, etiology and outcome of pneumonia among cancer patients in an oncology intensive care unit from Eastern India

With the rising incidence of cancer in low and lower-middle-income countries, the burden of pneumonia, which causes disproportionate morbidity and mortality in cancer patients, presents an evidence gap. We conducted a 1-year prospective cohort study in the oncology ICU at Tata Medical Center Kolkata, to determine the incidence, risk factors, etiology and impact of pneumonia on length of stay and mortality. Pneumonia was identified via daily ICU rounds using clinical and radiological features. A 1:1 age and sex matched comparison cohort without pneumonia was included. Etiology of pneumonia was determined using microscopy, culture, ELISA, PCR and cartridge-based nucleic acid amplification tests. Logistic regression was used to study risk factors, Cox regression for mortality and linear regression for hospital and ICU length of stay. There were 2279 ICU admissions. We recruited 711 patients: 355 had pneumonia, 356 did not. The incidence of pneumonia was 15.6% (95% CI: 14.1%-17.1%); 51.8% were community-acquired (CAP) and 48.2% were hospital-acquired (HAP). Seventy percent of CAP patients experienced recent healthcare exposure, with 28% hospitalised. All-cause 90-day mortality (6.4 per 1000 person-days) was 9 times higher in pneumonia patients. Lengths of hospital stay (18.6 days), ICU stay (10.9 days) and mechanical ventilation (2 days) were higher in pneumonia patients. Seventy-three percent of pneumonia patients had positive microbiology from lower respiratory samples. Gram-negative bacilli were frequent in both CAP and HAP. Influenza A/B was frequent in the monsoon and <i>Haemophilus influenzae</i> in the winter. Bone-marrow transplant, hematological malignancies, neutropenia and chronic obstructive pulmonary disease increased pneumonia risk. CAP, hematological malignancies and neutropenia increased the risk of death by day 90. Pneumonia, both CAP and HAP, increased mortality and hospital and ICU length of stay in adults with cancer. Gram-negative bacilli were common in both CAP and HAP. Tailored infection control programmes and an emphasis on adult vaccination are imperative to pneumonia prevention.

Authors

Institutions

Publication Details

Journal
ecancermedicalscience
Published
2025-08-19
DOI
https://doi.org/10.3332/ecancer.2025.1970
Primary Topic
Neutropenia and Cancer Infections
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A prospective cohort study of the incidence, etiology and outcome of pneumonia among cancer patients in an oncology intensive care unit from Eastern India

Saugata Sen, Santanu Bagchi, Sudipta Mukherjee, Gaurav Goel et al.
ecancermedicalscience
Neutropenia and Cancer Infections
article

A prospective cohort study of the incidence, etiology and outcome of pneumonia among cancer patients in an oncology intensive care unit from Eastern India

Saugata Sen, Santanu Bagchi, Sudipta Mukherjee, Gaurav Goel, Sangeeta Bhattacharya, Debashree Guha Adhya, S. N. Chatterji, Simran Malik, Sanjay Bhattacharya, Pralay Shankar Ghosh
article en

Abstract

With the rising incidence of cancer in low and lower-middle-income countries, the burden of pneumonia, which causes disproportionate morbidity and mortality in cancer patients, presents an evidence gap. We conducted a 1-year prospective cohort study in the oncology ICU at Tata Medical Center Kolkata, to determine the incidence, risk factors, etiology and impact of pneumonia on length of stay and mortality. Pneumonia was identified via daily ICU rounds using clinical and radiological features. A 1:1 age and sex matched comparison cohort without pneumonia was included. Etiology of pneumonia was determined using microscopy, culture, ELISA, PCR and cartridge-based nucleic acid amplification tests. Logistic regression was used to study risk factors, Cox regression for mortality and linear regression for hospital and ICU length of stay. There were 2279 ICU admissions. We recruited 711 patients: 355 had pneumonia, 356 did not. The incidence of pneumonia was 15.6% (95% CI: 14.1%-17.1%); 51.8% were community-acquired (CAP) and 48.2% were hospital-acquired (HAP). Seventy percent of CAP patients experienced recent healthcare exposure, with 28% hospitalised. All-cause 90-day mortality (6.4 per 1000 person-days) was 9 times higher in pneumonia patients. Lengths of hospital stay (18.6 days), ICU stay (10.9 days) and mechanical ventilation (2 days) were higher in pneumonia patients. Seventy-three percent of pneumonia patients had positive microbiology from lower respiratory samples. Gram-negative bacilli were frequent in both CAP and HAP. Influenza A/B was frequent in the monsoon and <i>Haemophilus influenzae</i> in the winter. Bone-marrow transplant, hematological malignancies, neutropenia and chronic obstructive pulmonary disease increased pneumonia risk. CAP, hematological malignancies and neutropenia increased the risk of death by day 90. Pneumonia, both CAP and HAP, increased mortality and hospital and ICU length of stay in adults with cancer. Gram-negative bacilli were common in both CAP and HAP. Tailored infection control programmes and an emphasis on adult vaccination are imperative to pneumonia prevention.

ecancermedicalscienceVol. 19
Indian Institute of Technology Kharagpur (IN), Tata Medical Center (IN)
Good health and well-being
Openalex Percentile: Top 70%
Neutropenia and Cancer Infections
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.